- In April 2023, Eli Lilly and Company launched a next-generation connected insulin pump system designed to improve glucose management and patient adherence through advanced digital monitoring and integration with mobile health apps. This development emphasizes Eli Lilly’s commitment to enhancing diabetes care with innovative technology.
- In March 2023, Tandem Diabetes Care, Inc. introduced its updated t:slim X2 insulin pump featuring automated insulin delivery capabilities and enhanced user interface, aimed at improving patient convenience and treatment outcomes in both pediatric and adult populations.
- In March 2023, Dexcom, Inc. expanded its continuous glucose monitoring (CGM) device offerings with the release of a more compact, accurate, and longer-lasting sensor, reflecting ongoing innovation in real-time glucose tracking technology.
- In February 2023, Abbott Laboratories received FDA approval for its latest FreeStyle Libre device, which integrates seamlessly with insulin delivery systems to provide comprehensive diabetes management, marking a significant step toward personalized patient care.
- In January 2023, Medtronic plc announced a strategic partnership with digital health companies to develop AI-driven insulin delivery solutions that optimize dosing and predict glucose trends, demonstrating a forward-looking approach to automated diabetes management.
